Go‘daklarda pnevmoniyaning klinik kechishi va dispeptik sindrom og‘irligiga probiotik terapiyaning ta’siri

The article presents the results of an evaluation of the efficacy of incorporating the probiotic strain L.reuteri into the comprehensive treatment of pneumonia accompanied by dyspeptic syndrome in infants. A total of 120 infants (aged under one year) with community-acquired pneumonia and dyspeptic symptoms were examined. The study group consisted of 50 infants receiving standard therapy combined with “Lactobacillus reuteri”; the comparison group comprised 50 infants receiving standard therapy without the probiotic; and the control group included 20 apparently healthy infants. The study evaluated the dynamics of clinical manifestations, the duration of dyspeptic syndrome, the time required for the normalization of body temperature, appetite, and stool, the length of hospital stay, and laboratory markers of inflammation. The inclusion of L.reuteri in the treatment regimen was associated with a more rapid reduction in the severity of dyspeptic symptoms and a shorter hospital stay. These results suggest that probiotic supplementation is a promising adjunct to the comprehensive treatment of infants presenting with concurrent pneumonia and dyspeptic syndrome.

Hali tarjima qilinmagan